Finance

Lists
KAEF:IDX
Kimia Farma (Persero) Tbk PT
436,00 IDR
+1,40%
(+6,00) 1D
9-окт., 16:11:24 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KAEF...
Open
434 IDR
High
440 IDR
Low
428 IDR
Mkt. cap
2,43 трлн
Avg. vol.
3,95 млн
Volume
623,60 миң
52-wk high
785 IDR
52-wk low
380 IDR
EPS
-77 IDR
Shares outstanding
5,57 млд
No. of employees
9 миң
Open
434 IDR
High
440 IDR
Low
428 IDR
Mkt. cap
2,43 трлн
Avg. vol.
3,95 млн
Volume
623,60 миң
52-wk high
785 IDR
52-wk low
380 IDR
EPS
-77 IDR
Shares outstanding
5,57 млд
No. of employees
9 миң
News stories
From web sources and news partners
Profile
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta. Wikipedia
About Kimia Farma (Persero) Tbk PT
CEO-
Employees9,36 миң
Founded1971-ж., 16-авг.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,64 трлн
2,22 трлн
2,03 трлн
2,67 трлн
Cost of goods sold
1,85 трлн
1,56 трлн
1,29 трлн
1,86 трлн
Cost of revenue
1,85 трлн
1,56 трлн
1,29 трлн
1,86 трлн
Research and development expenses
5,03 млд
7,54 млд
3,20 млд
10,39 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
709,79 млд
663,87 млд
640,94 млд
620,33 млд
Operating expense
766,80 млд
877,17 млд
669,20 млд
722,39 млд
Total operating expenses
2,62 трлн
2,44 трлн
1,96 трлн
2,59 трлн
Operating income
23,59 млд
-222,99 млд
67,93 млд
84,77 млд
Other non operating income
-2,92 млд
173,66 млд
159,00 млд
-26,56 млд
EBT including unusual items
-94,33 млд
-223,75 млд
127,96 млд
-60,16 млд
EBT excluding unusual items
-93,48 млд
-260,76 млд
127,95 млд
-60,19 млд
Income tax expense
4,17 млд
-14,50 млд
4,32 млд
9,40 млд
Effective tax rate
-4,42%
6,48%
3,37%
-15,62%
Other operating expenses
-37,43 млд
-36,20 млд
-12,78 млд
-9,74 млд
Net income
-84,72 млд
-155,23 млд
74,45 млд
-64,12 млд
Net profit margin
-3,21%
-7,01%
3,67%
-2,40%
Earnings per share
-
-
-
-
Interest and investment income
2,65 млд
10,77 млд
2,87 млд
8,13 млд
Interest expense
-115,65 млд
-221,53 млд
-110,15 млд
-125,81 млд
Net interest expenses
-112,99 млд
-210,75 млд
-107,28 млд
-117,68 млд
Depreciation and amortization charges
89,41 млд
175,98 млд
37,85 млд
101,42 млд
EBITDA
105,34 млд
-86,40 млд
125,64 млд
165,62 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору